Monaco Asset Management SAM »

Nektar Therapeutics shares owned by Monaco Asset Management SAM

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Monaco Asset Management SAM from 13F filings

Historical chart of Monaco Asset Management SAM investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Monaco Asset Management SAM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Monaco Asset Management SAM

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.1M 44k 25.84

More positions owned by Monaco Asset Management SAM

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Silver Tr Ishares Call Option (SLV)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Msci Brazil Etf Call Option (EWZ)
Microsoft Corporation Put Option (MSFT)
Costco Wholesale Corporation Put Option (COST)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
NVIDIA Corporation Put Option (NVDA)
Eli Lilly & Co. Put Option (LLY)
Viatris (VTRS)
AutoZone Put Option (AZO)
Patterson-UTI Energy (PTEN)
Vale S A Sponsored Ads (VALE)
Select Sector Spdr Tr Sbi Healthcare Put Option (XLV)
Lululemon Athletica (LULU)

View all positions for Monaco Asset Management SAM

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics